University of Alberta scientists find a new application for an existing drug, with potential to slow progression of the devastating degenerative disease.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig’s disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
The drug, called telbivudine, targets a protein that misfolds and does not function correctly in patients with ALS. “SOD1 is a protein that is known to misfold and misbehave in most cases of patients with ALS,” explained Ted Allison, associate professor in the Department of Biological Sciences and co-author on the study. “We showed that telbivudine can greatly reduce the toxic properties of SOD1, including improving the health of the subject’s motor neurons and improving movement.”
The research team used computer simulations to identify drugs with the potential for targeting the SOD1 protein. From this shortlist, the scientists identified and tested the most likely candidates—including telbivudine—using animal models.
“ALS is not well-understood,” said lead author Michele DuVal, who recently completed the PhD portion of the Faculty of Medicine & Dentistry’sMD/PhD program under the supervision of Allison. “We don’t yet know exactly what goes wrong first in the motor neurons or how the misbehaving SOD1 causes toxicity. Because there is still much to learn about the disease, the ALS research community focuses on both understanding ALS and on developing promising therapies.”
The discovery of telbivudine as a potential treatment is particularly exciting because the drug is already in use for treating patients with hepatitis. “It is already proven safe to use in patients, and it has very good potential for repurposing to use in a new clinical setting against ALS,” said Allison.
Learn more: Biologists identify promising drug for ALS treatment
The Latest on: Lou Gehrig’s disease
[google_news title=”” keyword=”Lou Gehrig’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Lou Gehrig’s disease
- Today in Sports - Lou Gehrig ends his streak of 2,130 consecutive games playedon May 1, 2024 at 7:00 am
2010 — Ryo Ishikawa shoots a 12-under 58 — the lowest score on a major tour — to win The Crowns in Togo, Japan. The 18-year-old Ishikawa has 12 birdies in his bogey-free round on the 6,545-yard Nagoya ...
- Old York Cellars' new wines to benefit women with Lou Gehrig’s diseaseon May 1, 2024 at 2:23 am
One-third of the proceeds of the new line of wines will go to Her ALS Story, which provides a community for women with ALS.
- This Date in Baseball - Lou Gehrig ends his streak of consecutive games at 2,130on April 30, 2024 at 5:00 pm
1939 — Lou Gehrig of the New York Yankees did not play against the Detroit Tigers at Briggs Stadium, ending at 2,130 his streak of consecutive games. Gehrig never played again. Babe Dahlgren took his ...
- Steve Gleason Isn’t Just Staying Alive. Steve Gleason Is Livingon April 30, 2024 at 5:00 pm
It has been 16 years since he retired from football; 13 years since he was diagnosed with amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease); 12 since he began using a wheelchair and had his ...
- Will the DEA reclassify marijuana as a Schedule III drug? What change means for Kentucky.on April 30, 2024 at 12:45 pm
USA Today reported that marijuana could be reclassified under the Controlled Substances Act from a Schedule I drug to a Schedule III drug. Marijuana has been considered a Schedule I drug since the ...
- 'I owe all of my success to him.' Legendary coach Ron Russo beloved by former runnerson April 30, 2024 at 6:21 am
Diagnosed with ALS in May 2023, Ron Russo spent 30 years coaching cross country and track in Cincinnati. His athletes, former teammates share stories.
- Borje Salming Miniseries Director Talks NHL Great: “He’s a King”on April 29, 2024 at 3:39 pm
He’s the most humble guy I ever met,” Amir Chamdin said of late Maple Leafs defenceman and NHL Hall of Famer ahead of Viaplay’s 'Borje – The Journey of a Legend’ getting an American premiere on May 2.
- Late Cincinnati millionaire leaves $13.5 million to ALS research at UC Gardner instituteon April 29, 2024 at 8:05 am
The estate of Hugh H. Hoffman gave the UC Gardner Neuroscience Institute a historic $13.5 million for ALS research and patient care ...
- Section III high school sports schedule, scoreboard for April 27on April 27, 2024 at 8:49 pm
The Section III high school sports schedule and scoreboard for Saturday, April 27. Syracuse.com is the only place to find a comprehensive schedule of all high school sporting events in Section III.
- Section III softball, baseball teams to take part in 15th annual Strike out Lou Gehrig’s Disease Classicon April 25, 2024 at 1:33 pm
Section III will have nine softball and 16 baseball teams participating in the 15th annual Strike out Lou Gehrig’s Disease Classic. Games are scheduled to start on Saturday.
via Bing News